Quarter | Prior | Estimate | Actual | Surprise | |
---|---|---|---|---|---|
Q4 2021 Pre-Market | EPS: REV: | ||||
Q4 2021 After-Hours | EPS: REV: | ||||
Q3 2021 After-Hours | EPS: REV: | 0.39 1.818B | |||
Q3 2021 Pre-Market | EPS: REV: | 0.59 155.002M | |||
Q2 2021 After-Hours | EPS: REV: | ||||
Q2 2021 Pre-Market | EPS: REV: | ||||
Q1 2021 After-Hours | EPS: REV: | 0.45 1.822B | |||
Q1 2021 Pre-Market | EPS: REV: | -0.62 85.097M | |||
Q4 2020 Pre-Market | EPS: REV: | 0.52 168.985M | 0.44 148.55M | 0.78 154.291M | 77.27% 3.86% |
Q4 2020 After-Hours | EPS: REV: | 0.45 1.881B | 0.41 1.89B | 0.41 1.925B | 0% 1.85% |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- Mid-Day Market Update: Dow Jumps 500 Points; AnaptysBio Shares Plunge
- Earnings Preview For The Week Of March 8
- Earnings Preview for DXP Enterprises
- ANI Pharmaceuticals's Earnings: A Preview
- Earnings Outlook for Cantel Medical
- A Preview Of ABM Industries's Earnings
- Earnings Outlook for Xeris Pharmaceuticals
- Earnings Preview: PQ Group Holdings
- Earnings Preview: Blueknight Energy
- Daqo New Energy's Earnings Outlook